Merus
Price & Volume
Stats
See moreOpen | $95.90 |
Previous Close | $95.76 |
Day Range | $95.81-$95.99 |
52W Range | $33.19-$96.28 |
Market Cap | $7.2B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $56.6M |
Revenue Growth (YoY) | 3.2% |
Gross Profit (12 Mos) | $20.9M |
Diluted EPS | -$5.28 |
News
See moreYahoo Finance • 3 days ago
Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights
Yahoo Finance • 8 days ago
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab
Yahoo Finance • 17 days ago
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote – GES, PINC, PRO, and MRUS
Yahoo Finance • 29 days ago
Merus (MRUS): Assessing Valuation After Recent 38% Stock Gain
About
CEO | Dr. Sven Ante Lundberg M.D. |
Address | Uppsalalaan 17, Utrecht, Netherlands, 3584 CT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 260 |
